KRYS: Krystal Biotech Inc
$153.25
1.35
(0.89%)
KRYS Performance Snapshot
1-Week Chg
1-Month Chg
3-Month Chg
6-Month Chg
1-Year Chg
Year-To-Date Chg
Beta 1-Year
0.78Beta 5-Year
0.75Volatility (10-Day)
1.19%KRYS Technical Snapshot
Datesorted descending | Close | Change 1D | Open | High | Low | Typical | Volume |
---|---|---|---|---|---|---|---|
2025-07-23 | $153.25 | $1.35 (0.89%) | $153.28 | $154.27 | $151.26 | $152.93 | 259.00K ($39.69M) |
2025-07-22 | $151.90 | $3.81 (2.57%) | $148.51 | $152.80 | $148.51 | $151.07 | 293.00K ($44.51M) |
2025-07-21 | $148.09 | $0.60 (0.41%) | $148 | $150.49 | $147.03 | $148.53 | 164.00K ($24.29M) |
2025-07-18 | $147.49 | -$2.66 (-1.77%) | $151.33 | $152.25 | $146.35 | $148.70 | 304.00K ($44.84M) |
2025-07-17 | $150.15 | $0.07 (0.05%) | $149.03 | $153.74 | $149.03 | $150.97 | 266.00K ($39.94M) |
2025-07-16 | $150.08 | $2.35 (1.59%) | $148.10 | $151.79 | $147.14 | $149.67 | 281.00K ($42.17M) |
2025-07-15 | $147.73 | -$2.68 (-1.78%) | $150.64 | $152.05 | $147.14 | $148.97 | 323.00K ($47.72M) |
2025-07-14 | $150.41 | $2.24 (1.51%) | $147.52 | $151.11 | $147.52 | $149.68 | 271.00K ($40.76M) |
2025-07-11 | $148.17 | -$1.57 (-1.05%) | $147.99 | $148.77 | $146.42 | $147.79 | 267.00K ($39.56M) |
2025-07-10 | $149.74 | $0.84 (0.56%) | $148.79 | $151.48 | $147.01 | $149.41 | 253.00K ($37.88M) |
KRYS Financial Snapshot
(USD)
2025 Q1
Y/Y CHANGE
Cash and equivalents
$308.77M
-13.99%Total assets
$1.07B
25.91%Total liabilities
$89.74M
66.02%Total investments
$456.55M
73.43%Shareholders' equity
$984.67M
23.20%Book value per share
$34.17
20.98%
(USD)
2025 Q1
Y/Y CHANGE
Revenue
$88.18M
94.88%Net income
$35.73M
3734.01%Operating expense
$46.98M
-5.12%Gross profit
$83.16M
94.15%EBITDA
$45.23M
1680.05%Earnings per share
$1.24
4033.33%
(USD)
2025 Q1
Y/Y CHANGE
Net change in cash
-$36.09M
-5423.75%Cash from operations
$30.97M
94.92%Cash from investing
-$54.77M
-110.81%Cash from financing
-$12.47M
-217.79%Free cash flow
$25.20M
72.27%Free cash flow per share
$0.88
69.25%
(USD)
2025 Q1
Y/Y CHANGE
Market capitalization
$5.19B
3.17%Enterprise value
$4.86B
3.68%Shares outstanding
28.81M
1.81%Profit margin
40.50%
1828.57%Gross margin
94.30%
-0.42%EBITDA margin
51.30%
816.07%
(USD)
2025 Q1
Y/Y CHANGE
Dividend yield
0%
0%Dividends per share
$0
0%Dividend growth
-
-Payout ratio
0%
0%Coverage ratio
-
-Current ratio
9.65
-23.77%